Nuvation Bio Inc

NUVBNYSE · USD
6.14USD+0.07 (+1.08%)
1210

Nuvation Bio Inc (NUVB) Straddle

NUVB straddle scan found 17 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 59.6%.

Read more

Trading a NUVB straddle lets you take a pure volatility position on Nuvation Bio Inc without committing to a direction. Nuvation Bio Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate NUVB straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on NUVB profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Nuvation Bio Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the NUVB straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer.

The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the NUVB straddle is the cleanest expression of that view. Our scanner prices every NUVB straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a NUVB straddle into a catalyst or short a NUVB straddle to harvest decay, the options straddle setups that matter are all in one place.

Jan 21, 202817.50$12.5849012%59.6%$30.08$4.930
Dec 18, 20267.50$2.059112%57.3%$9.55$5.45249
Mar 19, 202712.50$6.9818212%56.3%$19.48$5.530
Jan 21, 202812.50$8.2049012%55.9%$20.70$4.302
Jan 21, 202810.00$6.1849012%53.6%$16.18$3.83307
Jan 21, 202815.00$10.8349012%53.1%$25.83$4.1851
Mar 19, 202710.00$4.9818212%51.3%$14.98$5.030
Nov 20, 20267.50$2.206312%48.1%$9.70$5.300
Jan 21, 20287.50$4.5549012%47.7%$12.05$2.95181
Mar 19, 20277.50$3.2318212%46.3%$10.73$4.2821

As of September 21, 2026

Find the right straddle before volatility moves

Track NUVB straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial